MedTrace Logo

Effects of Explosive Plyometric Training Versus Thera-Band Power Training on Sprint Swimming Performance

NCT07791693 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-08-28

No results posted yet for this study

Summary

This randomized controlled trial will compare the effects of upper-limb explosive plyometric training and TheraBand-based power training on sprint swimming performance in competitive swimmers. Participants will be randomly allocated to either an explosive plyometric training group or a TheraBand-based power training group. Both groups will continue their routine aquatic training while completing their assigned dry-land training program for eight weeks. Outcomes including 50-meter freestyle performance, Medicine Ball Throw Test performance, and 15-meter sprint time will be assessed at baseline and after completion of the intervention. The study aims to determine which upper-limb training approach is more effective for improving sprint swimming performance.

Conditions

  • Sports Physical Therapy

Interventions

OTHER

Closed-Chain Explosive Plyometric Training

Participants will perform a structured upper-limb explosive plyometric training program three times per week for eight weeks in addition to their routine aquatic training. The program will include explosive push-ups, medicine ball chest passes, overhead medicine ball throws, plyometric push-ups, and other upper-limb power drills using progressive overload.

OTHER

Open-Chain TheraBand-Based Power Training

Participants will perform a structured upper-limb power training program using progressive TheraBand resistance three times per week for eight weeks in addition to their routine aquatic training. Exercises will target the shoulder girdle, upper arm, and scapular stabilizers through controlled movements related to freestyle swimming. Resistance will be progressively increased according to participants' performance and tolerance.

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Zobia Naseem, MS-SPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
17 Years
Max Age
25 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2026-11-30
Completion
2026-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07791693 on ClinicalTrials.gov